甲状腺功能正常的2型糖尿病患者中游离三碘甲状腺原氨酸与糖尿病周围神经病变的相关性
研究纳入1422例住院2型糖尿病患者,均行肌电图检查,36.5%诊断为糖尿病周围神经病变(DPN)。DPN患者血清游离三碘甲状腺原氨酸(FT3)显著低于无DPN者(4.08±0.64 vs 4.39±0.63 pmol/L,P<.001),多因素校正后FT3与DPN风险的负相关仍显著,孟德尔随机化分析提示FT3对DPN风险有因果效应。
要点
- 1422例甲状腺功能正常的2型糖尿病患者中,36.5%诊断为糖尿病周围神经病变。
- DPN患者血清FT3显著低于无DPN者(4.08±0.64 vs 4.39±0.63 pmol/L,P<.001)。
- 多因素校正后FT3与DPN风险的负相关仍显著,孟德尔随机化提示因果效应。
核心结论
- 低FT3是甲状腺功能正常的2型糖尿病患者发生糖尿病周围神经病变的危险因素。
研究设计与样本
- 研究纳入来自复旦大学附属中山医院的1422例住院2型糖尿病患者,所有参与者均接受肌电图检查,包括神经传导速度、远端运动与感觉潜伏期、感觉神经动作电位波幅和复合肌肉动作电位波幅。
主要发现
- 519例(36.5%)2型糖尿病患者根据临床症状和肌电图结果可诊断为糖尿病周围神经病变。
- 与无DPN者相比,DPN患者糖尿病病程更长、血糖控制更差、BMI水平更低,同时糖尿病视网膜病变、糖尿病肾病和心血管疾病的比例更高(均P<.05)。
- DPN患者血清FT3水平显著低于无DPN者(4.08±0.64 vs 4.39±0.63 pmol/L,P<.001)。
- 在DPN患者中,FT3与所测全部神经的远端运动潜伏期和远端感觉潜伏期呈负相关,与复合肌肉动作电位波幅、感觉神经动作电位波幅和神经传导速度呈正相关(均P<.05)。
- 对潜在混杂因素进行多因素校正后,血清FT3与DPN风险之间的负相关仍然显著(P<.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the relationship between free triiodothyronine (FT3) and diabetic peripheral neuropathy (DPN) in euthyroid patients with type 2 diabetes mellitus. METHODS: We enrolled 1422 hospitalized patients with type 2 diabetes from Zhongshan Hospital, Fudan University. All participants underwent electromyographic examinations, including nerve conduction velocity (NCV), distal motor and sensor latency (DML and DSL), sensory nerve action potential (SNAP) amplitude, and compound muscle action potential (CMAP) amplitude. RESULTS: A total of 519 (36.5%) patients with type 2 diabetes could be diagnosed as DPN according to their clinical symptoms and results of electromyography. Compared with those without DPN, the patients with DPN had a longer duration of diabetes, poorer blood glucose control, and lower BMI levels, accompanied with higher proportions of diabetic retinopathy, diabetic nephropathy, and cardiovascular disease (all P < .05). Serum FT3 level were significantly lower in patients with DPN than those without DPN (4.08 ± 0.64 vs 4.39 ± 0.63 pmol/L, P < .001), and FT3 was inversely correlated with the nerve DML and DSL, and positively correlated with the CMAP, SNAP, and NCV of all nerves we measured in the patients with DPN (all P < .05). The inverse correlation between serum FT3 and risk of DPN remained significant after multivariate adjustment for potential confounders (P < .05). A Mendelian randomization analysis also indicated a causal effect of serum FT3 on the risk of DPN. CONCLUSION: Low FT3 is a risk factor of DPN among euthyroid patients with type 2 diabetes.
引用
- Xu B, Yang X, Ma Y, et al. Association Between Free Triiodothyronine and Diabetic Peripheral Neuropathy in Euthyroid Patients With Type 2 Diabetes. J Clin Endocrinol Metab. 2025. PMID: 40420814. doi:10.1210/clinem/dgaf304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。